Capecitabine in Combination With Docetaxel in First Line in HER2-Negative Metastatic Breast Cancer: An Observational Study
Pathology and Oncology Research - Netherlands
doi 10.1007/s12253-016-0129-7
Full Text
Open PDFAbstract
Available in full text
Date
October 22, 2016
Authors
Publisher
Springer Science and Business Media LLC